Search

Your search keyword '"Lagrou, Katrien"' showing total 1,344 results

Search Constraints

Start Over You searched for: Author "Lagrou, Katrien" Remove constraint Author: "Lagrou, Katrien"
1,344 results on '"Lagrou, Katrien"'

Search Results

4. Risk factors for SARS-CoV-2 infection and severe COVID-19 in unvaccinated solid organ transplant recipients

6. Evolutionary origin and population diversity of a cryptic hybrid pathogen

7. Nationwide quality assurance of high-throughput diagnostic molecular testing during the SARS-CoV-2 pandemic: role of the Belgian National Reference Centre

9. Predictors for Prolonged Hospital Stay Solely to Complete Intravenous Antifungal Treatment in Patients with Candidemia: Results from the ECMM Candida III Multinational European Observational Cohort Study

10. Damping excessive viral-induced IFN-γ rescues the impaired anti-Aspergillus host immune response in influenza-associated pulmonary aspergillosis

12. Attributable mortality of candidemia – Results from the ECMM Candida III multinational European Observational Cohort Study

14. Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG

15. Prognostic Impact of Bronchoalveolar Lavage Fluid Galactomannan and Aspergillus Culture Results on Survival in COVID-19 Intensive Care Unit Patients: a Post Hoc Analysis from the European Confederation of Medical Mycology (ECMM) COVID-19-Associated Pulmonary Aspergillosis Study

16. Guidelines for the management of Toxoplasma gondii infection and disease in patients with haematological malignancies and after haematopoietic stem-cell transplantation: guidelines from the 9th European Conference on Infections in Leukaemia, 2022

17. Lower respiratory tract single-cell RNA sequencing and neutrophil extracellular trap profiling of COVID-19-associated pulmonary aspergillosis: a single centre, retrospective, observational study

21. Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study

22. Diagnosis of Breakthrough Fungal Infections in the Clinical Mycology Laboratory: An ECMM Consensus Statement.

23. Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium

24. Fetal Diagnosis and Therapy during the COVID-19 Pandemic: Guidance on Behalf of the International Fetal Medicine and Surgery Society

25. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium

26. European candidaemia is characterised by notable differential epidemiology and susceptibility pattern: Results from the ECMM Candida III study

27. An observational cohort study of histological screening for BK polyomavirus nephropathy following viral replication in plasma

28. Characterization of Emerging Serotype 19A Pneumococcal Strains in Invasive Disease and Carriage, Belgium

29. Molecular detection of SARS-COV-2 in exhaled breath at the point-of-need

30. Lung epithelial and myeloid innate immunity in influenza-associated or COVID-19-associated pulmonary aspergillosis: an observational study

31. Full-genome next-generation sequencing of hepatitis C virus to assess the accuracy of genotyping by the commercial assay LiPA and the prevalence of resistance-associated substitutions in a Belgian cohort

32. Risk Factors for Intra-Abdominal Candidiasis in Intensive Care Units: Results from EUCANDICU Study

35. Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients—a multinational observational study by the European Confederation of Medical Mycology

37. A role for extensive SARS‐CoV‐2 virological assessment of donor and recipient in lung transplantation.

39. Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms.

40. First detection of triazole‐resistant aspergillus fumigatus harbouring the TR34/L98H Cyp51A mutation in Burkina Faso

41. Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease

42. Multinational Observational Cohort Study of COVID-19-Associated Pulmonary Aspergillosis

43. Visualizing in deceased COVID-19 patients how SARS-CoV-2 attacks the respiratory and olfactory mucosae but spares the olfactory bulb

44. Early SARS-CoV-2 Reinfections within 60 Days and Implications for Retesting Policies

45. Neuraminidase and SIGLEC15 modulate the host defense against pulmonary aspergillosis

47. Importance of Resolving Fungal Nomenclature: the Case of Multiple Pathogenic Species in the Cryptococcus Genus

48. Improving outcome of fungal diseases – Guiding experts and patients towards excellence

49. Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis

Catalog

Books, media, physical & digital resources